Demo Sign up Log In

West Pharmaceutical Services (WST)

Cost of Revenue

$2.10B

TTM · Period ending: Jun 30, 2026 · USD

WST Cost of Revenue

Latest reported$2.10Bperiod endingJun 30, 2026

Latest reported$2.10Bperiod endingJun 30, 2026

WST Cost of Revenue ($128.00M → $2.10B)

Annual cost of revenue

High-resolution chart · PNG

WST cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

West Pharmaceutical Services Cost of Revenue — Annual fiscal periods (USD)
Period ending	Cost of Revenue (USD)
Dec 31, 2025	1,970,400,000
Dec 31, 2024	1,890,500,000
Dec 31, 2023	1,818,400,000
Dec 31, 2022	1,746,600,000
Dec 31, 2021	1,657,300,000
Dec 31, 2020	1,378,800,000
Dec 31, 2019	1,234,800,000
Dec 31, 2018	1,171,700,000
Dec 31, 2017	1,085,400,000
Dec 31, 2016	1,008,100,000
Dec 31, 2015	943,900,000
Dec 31, 2014	973,800,000
Dec 31, 2013	938,700,000
Dec 31, 2012	878,600,000
Dec 31, 2011	853,600,000
Dec 31, 2010	787,100,000
Dec 31, 2009	752,100,000
Dec 31, 2008	748,500,000
Dec 31, 2007	728,300,000
Dec 31, 2006	651,500,000
Dec 31, 2005	505,900,000
Dec 31, 2004	374,100,000
Dec 31, 2003	334,900,000
Dec 31, 2002	302,100,000
Dec 31, 2001	280,800,000
Dec 31, 2000	289,700,000
Dec 31, 1999	289,100,000
Dec 31, 1998	282,200,000
Dec 31, 1997	288,500,000
Dec 31, 1996	302,000,000
Dec 31, 1995	265,100,000
Dec 31, 1994	225,900,000
Dec 31, 1993	222,100,000
Dec 31, 1992	217,800,000
Dec 31, 1991	221,400,000
Dec 31, 1990	221,500,000
Dec 31, 1989	206,700,000
Dec 31, 1988	197,400,000
Dec 31, 1987	174,400,000
Dec 31, 1986	160,200,000
Dec 31, 1985	128,000,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.